# A03-016 - Portfolio Registry Linking

## Program

Program A03 - Scientific Content Population: SSRIs.

## Phase

Phase 2 - Drug Portfolio Definition.

## Objective

Consolidate the official Program A03 registries into a single structural relationship layer.

## Created Artifacts

- `KnowledgeBase/SSRIs/Registry/MASTER_REGISTRY.json`
- `KnowledgeBase/SSRIs/Registry/MASTER_REGISTRY_INDEX.json`
- `KnowledgeBase/SSRIs/Registry/REGISTRY_DEPENDENCIES.json`
- `KnowledgeBase/SSRIs/Registry/REGISTRY_RELATIONSHIPS.json`
- `KnowledgeBase/SSRIs/Registry/REGISTRY_STATUS.json`

## Linked Registries

The master registry links:

- Drug Registry;
- Editorial Registry;
- Drug Portfolio Editorial Registry;
- Metadata Registry;
- Source Registry;
- Binding Registry;
- Template Registry;
- Directory Registry;
- related indexes and status registries.

## Validation Status

- All linked registry paths exist.
- No orphan registry was created.
- No duplicate relationship was created.
- No invalid cycle was introduced.
- All JSON artifacts are structurally valid.

## Explicit Non-Actions

This mission did not:

- create Drug Profiles;
- create scientific knowledge;
- interpret literature;
- create runtime objects;
- create Knowledge Graph entries;
- create Evidence Graph entries.

## Next Mission

```text
MISSION A03-017 - PORTFOLIO_TRACEABILITY_INITIALIZATION
```

## Declaration Final

A03-016 creates registry relationships only. It does not authorize scientific content population, clinical interpretation, recommendation, prescription or runtime consumption.
